摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

4,6-二氯-3-(2-氯乙基)-2-甲基喹啉 | 57521-14-9

中文名称
4,6-二氯-3-(2-氯乙基)-2-甲基喹啉
中文别名
——
英文名称
4,6-dichloro-3-(2-chloro-ethyl)-2-methyl-quinoline
英文别名
4,6-Dichlor-3-(2-chlor-aethyl)-2-methyl-chinolin;3-(2-chloroethyl)-4,6-dichloro-2-methylquinoline;4,6-Dichloro-3-(2-chloroethyl)-2-methylquinoline
4,6-二氯-3-(2-氯乙基)-2-甲基喹啉化学式
CAS
57521-14-9
化学式
C12H10Cl3N
mdl
——
分子量
274.577
InChiKey
UWRNWBVHBOCMTP-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    4.7
  • 重原子数:
    16
  • 可旋转键数:
    2
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.25
  • 拓扑面积:
    12.9
  • 氢给体数:
    0
  • 氢受体数:
    1

安全信息

  • 海关编码:
    2933499090

SDS

SDS:f16d4df06c9d2aeeed5b07f3128c6538
查看

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    4,6-二氯-3-(2-氯乙基)-2-甲基喹啉溶剂黄146 作用下, 反应 5.0h, 以95.6%的产率得到8-chloro-4-methyl-2,3-dihydro-furo[3,2-c]quinoline
    参考文献:
    名称:
    Potential antineoplastics. Synthesis and cytotoxicity of certain 4-chloro-3-(2-chloroethyl)-2-methylquinolines and related derivatives
    摘要:
    In an extension of our work in the field of nitrogen heterocycles with potential cytotoxic activity, the synthesis of some substituted 4-chloro-3-(2-chloroethyl)-2-methylquinolines (10-13) from their parent 3-[1-(phenylamino)ethylidene]-dihydro-2(3H)furanones (6-9) is reported. The conversion of 10-13 to some thieno-, furo- and pyrrolo[3,2-c]quinolines (14-27, 31-33) is also described. The compounds were evaluated for their toxicity in brine shrimp (Artemia salina), and their cytotoxicity against some clinically isolated human tumors in vitro. Several compounds exhibited good toxic activity against Artemia salina, while the furanone (6, NSC 680781) displayed good antineoplastic activity and high selectivity against some cell lines from leukemia, lung cancer, colon and melanoma panels. This compound has been selected by the NCI for further testing in a new in vivo anticancer hollow fiber assay.
    DOI:
    10.1016/s0223-5234(99)80067-1
  • 作为产物:
    描述:
    (3E)-3-[1-(4-chloroanilino)ethylidene]oxolan-2-one三氯氧磷 作用下, 反应 4.0h, 以94.7%的产率得到4,6-二氯-3-(2-氯乙基)-2-甲基喹啉
    参考文献:
    名称:
    Potential antineoplastics. Synthesis and cytotoxicity of certain 4-chloro-3-(2-chloroethyl)-2-methylquinolines and related derivatives
    摘要:
    In an extension of our work in the field of nitrogen heterocycles with potential cytotoxic activity, the synthesis of some substituted 4-chloro-3-(2-chloroethyl)-2-methylquinolines (10-13) from their parent 3-[1-(phenylamino)ethylidene]-dihydro-2(3H)furanones (6-9) is reported. The conversion of 10-13 to some thieno-, furo- and pyrrolo[3,2-c]quinolines (14-27, 31-33) is also described. The compounds were evaluated for their toxicity in brine shrimp (Artemia salina), and their cytotoxicity against some clinically isolated human tumors in vitro. Several compounds exhibited good toxic activity against Artemia salina, while the furanone (6, NSC 680781) displayed good antineoplastic activity and high selectivity against some cell lines from leukemia, lung cancer, colon and melanoma panels. This compound has been selected by the NCI for further testing in a new in vivo anticancer hollow fiber assay.
    DOI:
    10.1016/s0223-5234(99)80067-1
点击查看最新优质反应信息

文献信息

  • TOPICAL FORMULATIONS
    申请人:BECK Petra Helga
    公开号:US20100093691A1
    公开(公告)日:2010-04-15
    There is provided topical pharmaceutical compositions comprising compounds of formula I wherein R 1 , R 2 , R 3 and X have meanings given in the description. These compositions can be used to treat microbial infections and to kill clinically latent microorganisms.
    提供了一种含有I式化合物的局部制药组合物,其中R1、R2、R3和X的含义在说明中给出。这些组合物可用于治疗微生物感染并杀死临床潜伏微生物。
  • USE OF PYRROLOQUINOLINE COMPOUNDS TO KILL CLINICALLY LATENT MICROORGANISMS
    申请人:Beck Petra Helga
    公开号:US20120231995A1
    公开(公告)日:2012-09-13
    There is provided the use of compounds of formula I wherein R 1 , R 2 , R 3 and X have meanings given in the description, for the preparation of a medicament for killing clinically latent microorganisms. There is also provided the use of compounds of formula I for treating microbial infections, as well as certain compounds of formula I per se.
    提供了使用式子I中的化合物,其中R1、R2、R3和X的含义在说明中给出,用于制备杀死临床潜伏微生物的药物。还提供了使用式子I中的化合物治疗微生物感染的方法,以及某些式子I中的化合物本身。
  • Raja, T K; Muthuvijayan, G; Reddy, P A, Indian Journal of Chemistry - Section B Organic and Medicinal Chemistry, 1992, vol. 31, # 4, p. 270 - 272
    作者:Raja, T K、Muthuvijayan, G、Reddy, P A、Lakshmanan, J、Divakar, R
    DOI:——
    日期:——
  • Ozawa et al., Yakugaku Zasshi/Journal of the Pharmaceutical Society of Japan, 1955, vol. 75, p. 1407,1409
    作者:Ozawa et al.
    DOI:——
    日期:——
  • US8207187B2
    申请人:——
    公开号:US8207187B2
    公开(公告)日:2012-06-26
查看更多